
right click image to download
Research Directory
1615 Poydras Street - Suite 1000
New Orleans, LA 70112
504.525.5744 voice
504.525.7787 fax |
Cherie Ann Nathan, MD
Louisiana State University Health Sciences - Shreveport
Areas of Research: Cancer Virotherapy
The eukaryotic translation initiation factor 4E (eIF4E) is overexpressed
in a variety of solid tumors and in particular in all HNSCC. The
biologic importance of eIF4E in HNSCC is underscored by the finding
that eIF4E overexpression in surgical margins increases the risk
of recurrence by 6.5 fold compared to patients with eIF4E negative
margins and is an independent risk factor for recurrence. This
was compared to p53 overexpression in the margins and found to
be a more sensitive marker for recurrence. When eIF4E, the protein
translation factor, is overexpressed in HNSCC it increases the
translation of weak mRNAs two of which have been found to be potent
angiogenic factors b-FGF and VEGF. In an earlier study an episomal
vector containing antisense RNA to eIF4E reduced the level of eIF4E
in a HNSCC cell line and suppressed both the tumorigenic and angiogenic
properties of the cells as demonstrated by loss of capacity to
grow in soft agar, reduced expression of angiogenic factors and
loss of tumorigenicity in nude mice (DeFatta, Laryngosopce 2000).
We intend to decrease the recurrence rate in this group of patients
with eIF4E positive margins with a eIF4E antisense adenovirus vector
thus decreasing the potential conversion of these occult cells
into the malignant phenotype.
Our goal is to establish eIF4E antisense adenoviral vectors, demonstrate
that this vector suppresses the growth of established tumors of
the head and neck in cell culture and in animal models, and finally
to develop a microscopic residual model which mimics the postsurgical
environment of head and neck cancer patients.
Selected Publications
Nathan, C.A., Amirghahari, N., Rong, X., Giordano,
T., Sibley, D., Nordberg, M., Glass, J., Agarwal, A., and Caldito,
G. mTOR inhibitors as possible adjuvant therapy for microscopic
residual disease in Head and Neck Squamous Cell Cancer. Cancer
Research, (2007)
Ye, G., Burton, G.V., Nathan, C.A., and Ampil,
F.L. Squamous cell carcinoma of the oral cavity following breast
cancer treatment. Southern Medical Journal, (2006) 99(10):
1150-1151
Mathis, J.M., Williams, B.J., Sibley, D.A., Carroll, J.L., Li,
J., Odaka, Y., Barlow, S., Nathan, C.A., Li, B.D.,
and DeBenedetti, A. Cancer-specific targeting of an adenovirus-delivered
herpes simplex virus thymidines kinase suicide gene using translational
control. Journal of Gene Medicine, (2006)
McDuffie, C.M., Amirghahari, N., Caldito, G., Lian, T.S., Thompton,
L., and Nathan, C.A. Predictive factors for
proterior triangle metastasis in HNSCC. Laryngoscope, (2005)
December; 115(12): 2114-2117
Lee, M., Ramaswamy, M.R., Lilien, D.L., Nathan, C.A. Unilateral
vocal cord paralysis causes contralateral false-positive positron emission
tomography scans of the larynx. Annuals of Otol Rhinol Laryngol,
(2005) March; 114(3): 202-206
|